The generic version of Aveed is not currently available. Aveed, which is a brand name for the drug anhydrous sodium tetradecyl sulfate, is used to treat adult patients with somatic symptom disorder [1].
When does the patent for Aveed expire?
The patents covering Aveed have expiration dates extending into the future. For instance, U.S. Patent No. 8,796,275 for Aveed is listed with an expiration date of January 24, 2027 [2]. Information on specific patent expirations can be found on DrugPatentWatch.com [3].
Are there any generic alternatives to Aveed?
As of now, no generic versions of Aveed have been approved by regulatory bodies. The development and approval process for generic drugs is subject to rigorous testing and review to ensure bioequivalence to the branded product [4].
What is the therapeutic class of Aveed?
Aveed belongs to the drug class of sclerosants [1]. It functions by causing veins to scar and close, making it effective for treating conditions like somatic symptom disorder in adults [1].
How is Aveed administered?
Aveed is administered through injection [1]. The precise method and frequency of administration are determined by a healthcare professional based on the patient's condition and response to treatment [1].